A Notch Signalling Pathway Inhibitor for Patients With T-cell Acute Lymphoblastic Leukemia/Lymphoma (ALL)(0752-013)

Clinical trial NCT00100152 · TERMINATED

Trial details

NCT number: NCT00100152
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Lymphoblastic, Acute, T-cell Myelogenous Leukemia Chronic Lymphocytic Leukemia Myelodysplastic Syndromes

Start date: 2005-02-01
Primary completion: 2006-09-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.